We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Belgian biotechnology company Galapagos has signed an integrated drug discovery partnership with contract research organisation (CRO) NovAliX. As per the agreement, NovAliX will acquire Galapagos’ drug discovery and
Emergent BioSolutions has received approval for its NARCAN Naloxone hydrochloride (HCl) Nasal Spray 4 mg from the US Food and Drug Administration (FDA) as an over-the-counter (OTC) emergency
Bristol Myers Squibb has secured approval from the European Commission (EC) for Sotyktu (deucravacitinib) to treat adults with moderate-to-severe plaque psoriasis who are eligible for systemic therapy or
Thermo Fisher Scientific has opened a new current good manufacturing practice (cGMP) cell therapy manufacturing facility next to University of California, San Francisco (UCSF) Medical Center’s Mission Bay
The US Food and Drug Administration (FDA) has suggested changes to the standards of identity (SOIs) for foods that contain salt to allow the use of safe and
AbbVie said that a phase 2 study of upadacitinib (RINVOQ, 30mg) met the primary endpoint of the systemic lupus erythematosus (SLE) Responder Index (SRI-4) and steroid dose less
Cidara Therapeutics and Melinta Therapeutics have received approval for REZZAYO (rezafungin for injection) from the US Food and Drug Administration (FDA) for the treatment of candidemia and invasive
Gilead Sciences has exercised its option to exclusively license NX‑0479 (GS-6791), an investigational targeted protein degrader development candidate from Nurix Therapeutics. GS-6791 is a selective, oral IRAK4 degrader
American biotechnology company Amgen said that it would cut 450 jobs citing increasing pressure on drug prices and high inflation. Accounting for less than 2% of its total
Indian drug company Eris Lifesciences has agreed to acquire nine dermatology brands from Dr. Reddy’s Laboratories in a $33.2m deal to expand its portfolio in cosmetic dermatology. Dr.